搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
18 分钟
A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
pharmaphorum
33 分钟
Alarm bell rings for GSK as US policy dents RSV jab sales
A solid showing for HIV drugs sold by majority-owned ViiV Healthcare and speciality medicines like cancer therapies Zejula ...
36 分钟
on MSN
Is Eli Lilly Stock a Buy?
Powered by its popular GLP-1 weight loss drugs, Eli Lilly's stock (NYSE: LLY) has had a strong run this year, up more than 55 ...
pharmaphorum
1 小时
Lilly touts new Kisunla regimen that reduces side effects
Eli Lilly says a new starting dose regimen for its Alzheimer's disease therapy Kisunla reduces the risk of side effects that ...
devdiscourse
3 小时
Global Health: Breakthroughs, Challenges, and Controversies
This summary highlights recent health news including the bird flu outbreak in Romania, Alzheimer's drug trials by Coya ...
Daily
4 小时
Eli Lilly Kisunla bags marketing authorization in Great Britain to treat mild cognitive ...
Eli Lilly and Company. "Donanemab demonstrated meaningful results for people with early symptomatic Alzheimer's disease by ...
Monthly Prescribing Reference
11 小时
Study Shows Modified Donanemab Titration Regimen Cuts Risk of ARIA-E
Modified titration was associated with a 41% lower relative risk of ARIA-E than the standard dosing regimen. Topline results were announced from a phase 3b trial evaluating various dosing regimens of ...
11 小时
Gradual dosing of Lilly Alzheimer's drug cuts brain-swelling risk, study finds
Starting on a more gradual dosing schedule of Eli Lilly's Alzheimer's drug Kisunla cut the percentage of patients ...
12 小时
Eli Lilly Q3 earnings expected to beat Wall Street expectations
Eli Lilly is set to report Q3 earnings Wednesday, as the pharma giant continues to gain market share in the weight loss drug ...
来自MSN
12 小时
Can Mounjaro, Zepbound Help Eli Lilly Top Earnings Estimates Again?
Eli Lilly LLY will report its third-quarter 2024 earnings on Oct. 30, before market open. The Zacks Consensus Estimate for ...
13 小时
Eli Lilly says Donanemab redudced ARIA-E in early Alzheimer’s patients
Eli Lilly (LLY) announced “positive results” from the TRAILBLAZER-ALZ 6 Phase 3b study, showing a reduction in amyloid-related ...
FiercePharma
13 小时
Modified dosing regimen of Eli Lilly's Alzheimer's drug leads to significant reduction in ...
A small tweak in the dosing regimen of Eli Lilly’s Alzheimer’s disease drug Kisunla has reduced brain swelling of patients in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈